Exclusive: Gsk Eyes Replacing Human Genome Board

Reuters: Top News, Reuters
Wed, 05/30/2012 - 9:53am

NEW YORK/LONDON (Reuters) - GlaxoSmithKline Plc plans to launch a campaign to replace the entire board of Human Genome Sciences Inc with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech company, sources familiar with the situation said on Wednesday.

NEXT
Sections:  business   
RELATED ARTICLES
  • Bayer to pay $1.1B for California firm Conceptus
    Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
  • As drug industry’s influence over research grows, so does the potential for bias
    For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best. More
  • Drug Makers Stalled in a Cycle of Quality Lapses and Shortages
    ...These recent quality lapses at big drug companies show that contamination and shoddy practices extend well beyond the loosely regulated compounding pharmacies that have attracted attention because of their link to an outbreak of meningitis... [S]everal industry observers and former plant employees said that the recent quality issues were troubling and that manufacturers had been reluctant to fix problems because stopping production was simply too costly in a business where profits were driven by volume. More
  • Exclusive: GSK set for Human Genome takeover
    GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer. More
  • GlaxoSmithKline to pay $3B for health fraud
    British drugmaker GlaxoSmithKline will pay $3 billion in fines - the largest health care fraud settlement in U.S. history - for criminal and civil violations involving 10 drugs that are taken by millions of people. The Justice Department said Monday that GlaxoSmithKline PLC will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses. More

 

Comment On This Story

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News

  • I’m a model, and I’ve seen firsthand how AI can manipulate the fashion industry
    Fast Company, Wednesday - 12/18/2024 - 09:30 AM

    New York’s Fashion Workers Act would create basic labor protections for models—including around digital replicas and AI-generated content. If you follow fashion, you’re undoubtedly familiar with New York Fashion Week. It’s more than a series of runway shows; it’s a cornerstone of the global fashion industry—a vibrant celebration of creativity that brings together the most talented designers and artists in the world.

    More | Talk | Read It Later | Share
  • Elon Musk’s Grok-2 is now free—and it’s a mess
    Fast Company, Wednesday - 12/18/2024 - 09:00 AM

    Grok-2 has now made fun of Elon Musk, found an enemy in Mark Cuban, and sparked alt-right backlash. Late Friday night, Elon Musk’s xAI opened up Grok-2 access to the masses. The model isn’t all that different from the original Grok, though the company claims it runs faster and has improved accuracy.

    More | Talk | Read It Later | Share
  • ‘My best friend’: Gen Zers are gushing about ChatGPT on TikTok
    Fast Company, Wednesday - 12/18/2024 - 05:11 AM

    Nearly a third of young people now use ChatGPT to complete tasks at work. “Me and ChatGPT,” reads one TikTok post with 13.4 million views. The video shows a girl joyfully running through a field, handing flowers to a blurred-out partner. Set to Arctic Monkeys’s “No. 1 Party Anthem,” it seems to be a modern-day love story.

    More | Talk | Read It Later | Share
  • Starbucks is on the cusp of a major barista strike
    Business Insider, Wednesday - 12/18/2024 - 01:12 AM

    People picketing outside a Starbucks store in New York's East Village in 2023 during the last Starbucks Workers United strike. Spencer Platt/Getty ImagesStarbucks' biggest workers union on Tuesday went forward to authorize a nationwide strike. It said that the coffee chain had not settled hundreds of unfair labor practice cases.

    More | Talk | Read It Later | Share
  • Databricks is raising a gigantic funding round
    Business Insider, Wednesday - 12/18/2024 - 12:18 AM

    Databricks' valuation jumped 44% from 2023. Smith Collection/Gado/Getty ImagesDatabricks is raising $10 billion, boosting its valuation to $62 billion. The funding round is led by Thrive Capital and includes major investors like Andreessen Horowitz. Databricks plans to invest in AI products, acquisitions, and international expansion. Databricks is raising $10 billion in its latest funding round, bringing its valuation to $62 billion, the AI startup said on Tuesday.

    More | Talk | Read It Later | Share
  • The head of Travis Kalanick's restaurant tech startup is leaving after 5 years
    Business Insider, Tuesday - 12/17/2024 - 11:51 PM

    Travis Kalanick's food empire has a new head for its restaurant tech business. Theo Wargo/WireImageGuido Gabrielli is leaving restaurant tech company Otter after five years, per a company email viewed by BI. Otter's new head is Ashvin Kumar, who most recently worked at fintech Affirm. Otter is a nearly $70 million a year business, Travis Kalanick wrote in an email to staff.

    More | Talk | Read It Later | Share